Why Britain’s GLP-1 Patients Are Paying for…

Ashwin Sharma, MD

Aug 17

11

1

1.5 million become collateral damage

Read →

1 Comment

kev

20h

If the reason UK pays less is because of the negotiating leverage of the NHS, then why was the cash-pay (non-negotiated) UK price so much lower than the U.S. cash price?

Expand full comment

Reply

Share

#nojs-banner { position: fixed; bottom: 0; left: 0; padding: 16px 16px 16px 32px; width: 100%; box-sizing: border-box; background: red; color: white; font-family: -apple-system, "Segoe UI", Roboto, Helvetica, Arial, sans-serif, "Apple Color Emoji", "Segoe UI Emoji", "Segoe UI Symbol"; font-size: 13px; line-height: 13px; } #nojs-banner a { color: inherit; text-decoration: underline; } This site requires JavaScript to run correctly. Please turn on JavaScript or unblock scripts